Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $19.0250 (2.92%) ($17.6700 - $19.0800) on Wed. Aug. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 37 | Latest Price | $19.0250(2.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -2.09% in a week (0% probabilities). VIXM(-35%) VXX(-33%) UUP(-18%) DRIV(-4%) XLC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.7(-59.53%) | Inflection Point | Yes | Resistance Level | $20.73 | 5 Day Moving Average | $19.6(-2.93%) | 10 Day Moving Average | $19.93(-4.54%) | 20 Day Moving Average | $20.73(-8.22%) | To recent high | -21.2% | To recent low | 13.2% | Market Cap | $2.41b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |